HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) All Versions of this Article: 0091270007311568v1 48/3/365    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Callaghan, R. Articles by Kerr, I. D. Search for Related Content PubMed PubMed Citation Articles by Callaghan, R. Articles by Kerr, I. D. Social Bookmarking                         What's this?

P-glycoprotein: So Many Ways to Turn It On

From Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom (Dr Callaghan and Miss Crowley); School of Biomedical Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom (Mr Potter and Dr Kerr).

Expression of the ABC transporter P-glycoprotein (P-gp or ABCB1) is associated with resistance to chemotherapy in cancer. However, early investigations into the regulation of ABCB1 expression revealed that the process is not a classical induction as observed for certain metabolizing enzymes. The process involves the cellular stress response pathway initiated by either inflicted (eg, chemotherapy damage) or endogenous (eg, hypoxia) factors. However, ABCB1 is also expressed in a number of noncancerous tissues. In particular, the protein is found at tissues providing a barrier or secretory function. The localization of ABCB1 in normal tissues will impact significantly on drug pharmacokinetics, in particular the absorption and elimination processes. This review also describes the mechanism underlying ABCB1 expression in noncancerous tissue, a process that does not involve the stress response.

Key Words: P-glycoprotein • ABCB1 • drug resistance • chemotherapy • drug elimination • drug absorption

Address for correspondence: Dr Richard Callaghan, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK; e-mail: richard.callaghan{at}ndcls.ox.ac.uk.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I. E. Stillman and M. Pavlakis Allograft Biopsies: Studying Them for All They're Worth J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2282 - 2284. [Full Text] [PDF]

				D. R. Foster, S. Yee, B. E. Bleske, P. L. Carver, M. J. Shea, S. S. Menon, C. Ramachandran, L. S. Welage, and G. L. Amidon Lack of Interaction Between the Peptidomimetic Substrates Captopril and Cephradine J. Clin. Pharmacol., March 1, 2009; 49(3): 360 - 367. [Abstract] [Full Text] [PDF]